← Archive

Already Committed, Still Reviewing, Still Global: The Maternity Payer Divide Is Legible Now, and September 1 Is the Deadline That Makes It Permanent

A payer-by-payer scorecard sorted from provider bulletins rather than press releases — and a correction to our August 5 characterization of commercial payer posture.

Pediatric Health Dispatch | Deep Dispatch | August 21, 2026

The Scorecard Wasn't Empty

A correction first.

The August 5 Deep Dispatch argued that CMS converted maternity unbundling from a market-wide billing reset into a payer-by-payer choice, and described commercial payer posture as uniformly silent. That characterization was accurate for Aetna, Cigna, and UnitedHealthcare, whose public coding guidance still describes the bundled global world. It was not accurate for the commercial market as a whole, and PHD should have caught it before publishing.

Geisinger Health Plan published a full four-phase operational conversion notice on May 15, 2026, committing to service-level maternity coding "consistently across all GHP plan offerings." That spans GHP's commercial, Medicaid, and CHIP lines under one framework, and it was dated six weeks before PHD's first maternity payment coverage and two months before CMS proposed the G-code exit ramp on July 14. At least one commercial payer chose the CPT path before it was offered an alternative.

The fuller picture, assembled from provider bulletins rather than press releases, divides the payer market into three groups.

The first group is already converting. Geisinger published its operational notice in May. Priority Health (Michigan) told providers to begin billing antepartum visits as E/M encounters starting in June 2026. Blue Cross NC published maternity billing workflow changes in May, with encounter-level documentation required for 2027. Independent Health applied New York's E/M-plus-TH-modifier framework across all lines of business starting June 1. These are not aspirational statements: they are operational instructions to in-network OB practices.

The second group is publicly reviewing. Highmark published a transition notice stating it is reviewing policies and will issue operational guidance to providers later. That is not a commitment to the CPT path, but it is also not the bundled-global-preserving posture of the third group.

The third group still shows only legacy-global documentation. Aetna's clinical policy still instructs prenatal-only providers to use antepartum-only codes within the bundled framework. Cigna's Global Maternity Obstetric Package reimbursement policy is live. UnitedHealthcare's provider coding corner still frames obstetric unbundling as something to prevent within the existing global structure, not a transition to plan for. Elevance, Humana, Centene, Kaiser Permanente, and HCSC have not published comparable 2027 maternity transition notices.

The third bucket includes three of the four largest commercial carriers by covered lives. That is a significant data point. But "the big three are not yet committed" is a different claim than "commercial payers are silent," and precision matters when vendors are making infrastructure decisions based on the characterization.

On the state Medicaid side, the picture has shifted more dramatically. New York Medicaid required fee-for-service providers to begin billing prenatal visits as E/M encounters with the TH modifier for pregnancies starting June 1, 2026, with Medicaid managed care plan alignment requirements attached. North Carolina published a July 10 bulletin covering both Medicaid Direct and Managed Care, with TH-modifier transition starting September 1. MaineCare issued an August 6 bulletin requiring TH modifier use and encounter-level documentation by September 1, explicitly directing providers to move from total-visit tracking to individual encounter documentation. Michigan's July 15 provider alert confirmed a January 1, 2027 effective date with a public comment bulletin in September.

That is four states with clean implementation notices. Michigan's September bulletin will be the first with proposed component values. The others establish the operational expectation that the CPT path is coming, without yet setting prices.

The Mechanism Split Nobody Named

The scorecard is useful. The mechanism divergence is more important.

Joy Burkhard, CEO of the Policy Center for Maternal Mental Health, reported a finding from "Beyond the Bundle" technical-assistance sessions with more than 300 payers that has not surfaced in any trade coverage reviewed for this piece. When asked how they plan to address C-section morbidity and cost under the new code structure, Medicaid agencies and commercial plans named completely different levers.

Medicaid agencies said: payment restructuring. Under unbundled billing, cesarean delivery has its own code and its own price, decoupled from antepartum care. Several state Medicaid agencies confirmed they are actively considering modifying OB provider payment for C-sections to financially disincentivize medically unnecessary procedures. The payment lever. The claim is that when you can price a C-section separately, you can price it lower than the vaginal-delivery alternative, shifting the financial incentive at the point of delivery.

Commercial plans said: utilization management. The reach is toward benefit design, specifically excluding elective C-sections from member benefits, and stricter prior authorization for planned cesareans. The gatekeeping lever.

These produce structurally different operating environments for vendors, even when the vendor's clinical product is identical in both markets. A company selling C-section risk stratification into Medicaid is selling into a market where reduced C-section rates improve the payer's direct payment economics. That same company selling into a commercial book is selling into a market where reduced C-section rates improve a utilization metric. The revenue model, the sales narrative, and the actuarial business case built around the vendor's value proposition are all different. A single pricing deck does not fit both markets.

The TH modifier introduces a second mechanism divergence, this one with a concrete consumer-harm risk. USPSTF and WPSI guidelines already require cost sharing to be waived for preventive prenatal care and screenings under the ACA. Under the new framework, that waiver has to be triggered by the TH modifier appended to antepartum E/M claims. If a payer's claims processor is not configured to apply the waiver automatically when TH appears, commercially insured patients receive bills for prenatal visits that are supposed to be free. ACOG estimates roughly 93 percent of health plans are ACA-compliant on the underlying preventive-care obligation. The configuration question is whether the new billing hook triggers the waiver correctly in systems that have never seen a TH-modified prenatal E/M claim.

No commercial payer has published provider guidance confirming its claims system has been configured to handle TH-modified prenatal claims correctly. That is a consumer-harm risk with a January 1 fuse, and it is not currently observable from the outside.

The administrative overhead picture reinforces why the mechanism split matters beyond C-sections. A normal uncomplicated pregnancy moves from one bundled prenatal claim to roughly twelve to fourteen separately documented antepartum encounter claims before labor, plus delivery codes, plus postpartum encounter claims. That is not an incremental change to billing workflows; it is a structural revenue-cycle reengineering. Burkhard flagged independent and rural OB practices on thin margins as the most exposed to this shift. The vendor opportunity—maternity-specific RCM infrastructure to handle the new encounter-level documentation—is nameable. No well-funded startup has made it a core product yet.

September 1 Is the Operational Deadline

The September 14 comment deadline on the CMS G-code proposal is real and PHD will cover what the docket shows when it closes. But September 1 is the date that has already passed unnoticed in most maternity coverage, including PHD's own.

ACOG recommended that health plans begin accepting standard E/M codes for antepartum visits, without visit limits or prior authorization, by September 1, 2026. The logic is patient-level arithmetic. A pregnancy whose first prenatal visit falls on or after September 1 will deliver in May 2027 or later. The global obstetric codes do not exist after December 31, 2026. That pregnancy will straddle two billing regimes, and the provider will need to bill antepartum visits from 2027 forward using E/M codes, not the global prenatal codes the payer has accepted for decades.

A payer that has not stood up antepartum E/M acceptance by September 1 does not have a grace period. It has a denial queue, beginning with the first antepartum claim submitted in 2027 for a pregnancy that started in September. The denials are not an enforcement action or a regulatory penalty. They are the mechanical consequence of a claims processor encountering a code structure it has not been configured to accept.

The payers that have published conversion guidance — Geisinger, Priority Health, Blue Cross NC, Independent Health, New York Medicaid, North Carolina Medicaid, MaineCare — are positioned for September 1. Their networks can begin submitting antepartum E/M claims with reasonable confidence of payment. The payers with no public transition bulletin are not positioned, and their in-network providers cannot determine from any public document whether to begin transitioning or to wait.

The sequence that follows is genuinely awkward. ACOG set September 1 as the conversion deadline. CMS's comment window on whether payers must convert at all closes September 14. Payers that complete their E/M configuration by September 1 and then watch CMS finalize the G-code option in November have done operational work they were not required to do. Payers that wait for the November final rule before committing will have spent two months generating denials or deferring conversion during an active prenatal-visit season. There is no clean path through this calendar, and CMS created the conflict by proposing an optional exit from a process that was already underway.

For vendors and investors, the September 1 date resolves a key unknown before the November rule does. Payers publishing antepartum E/M acceptance guidance in August and early September are committing to the CPT path regardless of what CMS finalizes in November. Payers still silent after September 14 are the likely G-code adopters, not an undecided middle waiting on clarity. The useful market segmentation for anyone selling maternity infrastructure is no longer "converting versus not converting." It is "converting before September 1" versus "waiting for November."

One question the correction raises that the answer does not fully close: if Geisinger, Priority Health, Blue Cross NC, and Independent Health published conversion commitments before CMS offered them an alternative, will any of them walk back their notices after the G-code option is finalized? There is no evidence any of them will, and walking back a published provider notice generates the same operational abrasion from the other direction. But it is worth naming as a watch item, not as a risk that has materialized.

---

What we're watching

• Whether Aetna, Cigna, or UnitedHealthcare publishes a provider transition bulletin before or shortly after the September 1 deadline. Their continued silence through September 14, when the CMS comment window closes, would be the clearest available signal that the three largest commercial carriers intend to adopt the G-code path rather than the CPT framework. Their providers need an answer.
• Michigan's September 2026 policy bulletin on maternity component rates. This will be the first public data on whether unbundled Medicaid billing actually pencils out for OB practices — specifically, what E/M-level mix Michigan Medicaid proposes to pay for antepartum encounters that previously disappeared inside the global fee. If the component rates are below the bundled equivalent, the unbundling thesis for Medicaid-dependent providers weakens regardless of what the code structure says.
• Whether Centene, the largest Medicaid managed care book in the country with operations in 31 states, publishes a state-plan-level maternity transition notice in any of its markets before January 1, 2027. Centene's managed care plans cover a substantial share of the Medicaid pregnancies that New York, North Carolina, Maine, and Michigan are directing toward E/M billing. Whether Centene's plans align with state agency bulletins or preserve the bundled structure through a G-code-equivalent approach will determine whether the state-level commitments actually reach the patients they are meant to cover.

---